OnconiX AG
PrivateCompany Overview
OnconiX AG operates in Healthcare & Life Sciences and is based in Bern. It was founded in 2023.
OnconiX AG is a biotechnology company that develops patient-derived tumor models and AI-driven diagnostic platforms to enable personalized cancer therapy selection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OnconiX AG Comparables
Compare OnconiX AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProxyBio | 81% | |
| Curesponse | 81% | |
| SageMedic Corp. | 80% |
For institutional investors. Book with your work email.
OnconiX AG Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2026
Grew 100% QoQ from 3 to 6 employees.
For institutional investors. Book with your work email.
OnconiX AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OnconiX AG's valuation, stock price, and market status.
Is OnconiX AG a public or private company?
OnconiX AG is a private company.
What is the current stock price of OnconiX AG?
OnconiX AG is a private company, so its shares have no public market price. Caplight tracks OnconiX AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OnconiX AG worth (valuation)?
Valuation information for OnconiX AG is not publicly available.
Can I buy OnconiX AG stock?
OnconiX AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OnconiX AG's last funding round?
Funding round information for OnconiX AG is not publicly available.
Who are the main investors in OnconiX AG?
Investor information for OnconiX AG is not publicly disclosed.
Will OnconiX AG IPO soon?
No public IPO plans have been announced for OnconiX AG.
How can I track OnconiX AG secondary market activity?
Caplight tracks bids, offers, and trades in OnconiX AG's shares on secondary markets.